Steqeyma (ustekinumab-stba)

Steqeyma (ustekinumab) is a prescription medicine used to treat several inflammatory conditions:

  • Moderate to severe plaque psoriasis in adults and children over 6 years, when other systemic treatments have not worked or cannot be used.
  • Active psoriatic arthritis in adults when other disease-modifying anti-rheumatic drugs (DMARDs) are ineffective, either alone or with methotrexate.
  • Moderately to severely active Crohn’s disease in adults, when other treatments are inadequate or cannot be used.

Steqeyma is a biosimilar to Stelara.

Steqeyma (ustekinumab) is approved by the FDA in the USA and the EMA in the EU.

  • Disease Indications : Psoriasis
  • Usage : Subcutaneous
Medicine approved by
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)